Stocks in Play: Theratechnologies Inc.

Baystreet
2025.09.05 14:39
portai
I'm PortAI, I can summarize articles.

10:38 AM EST - Theratechnologies Inc. : Today announced the availability of EGRIFTA WR™ (tesamorelin) for injection for the reduction of excess abdominal fat in adult patients with HIV and lipodystrophy. The announcement follows the approval of EGRIFTA WR™ by the U.S. Food and Drug Administration (FDA) earlier this year. Theratechnologies Inc. shares T.TH are trading unchanged at $4.50.

10:38 AM EST - Theratechnologies Inc. : Today announced the availability of EGRIFTA WR™ (tesamorelin) for injection for the reduction of excess abdominal fat in adult patients with HIV and lipodystrophy. The announcement follows the approval of EGRIFTA WR™ by the U.S. Food and Drug Administration (FDA) earlier this year. Theratechnologies Inc. shares T.TH are trading unchanged at $4.50.

Source: Baystreet The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer